Abbott Selects Two Antigen Targets from Celera Genomics for Cancer Therapeutic Development

Apr 15, 2005

NEW YORK, April 15 (GenomeWeb News) - Celera Genomics announced yesterday that two of its antigen targets have been selected for further investigation by Abbott for cancer therapeutic development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Mission Bio Raises $10M in Series A Round
Different Microbial Communities Live Along Female Reproductive Tract
Biogen Joins Collaborators in Genetics Study of Alzheimer's, Down Syndrome
Aperiomics Raises $512K in Seed Funding
PlumCare Partners With PBKM FamiCord to Offer DNA Testing Service in Poland
OCD Risk Gene Candidates Unearthed in Sequencing Study

The Scan

A Mammoth Competition

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Genetic History, Diversity

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

To Long Life

Researchers link genetic links between education and smoking and longevity.

This Week in PNAS

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.

Main menu